"Cleveland Clinic is one of the largest and most respected hospitals in the country. Our mission is to provide better care of the sick, investigation into their problems, and further education of those who serve. Learn more about our leadership, vision, values and model of healthcare. Every life deserves world class care. Call or visit our website for appointment information."

During the past decade, Cleveland Clinic Cancer Center Strongsville conducted 66 clinical trials. In the 10-year time frame, 66 clinical trials started and 43 clinical trials were completed, i.e. on average, 65.2% percent of trials that started reached the finish line to date. In the past 5 years, 25 clinical trials started and 34 clinical trials were completed. i.e. 136% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cleveland Clinic Cancer Center Strongsville" #1 sponsor was "National Cancer Institute (NCI)" with 40 trials, followed by "SWOG Cancer Research Network" with 26 trials sponsored, "NRG Oncology" with 14 trials sponsored, "Alliance for Clinical Trials in Oncology" with 8 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 8 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cleveland Clinic Cancer Center Strongsville" #1 collaborator was "National Cancer Institute (NCI)" with 61 trials as a collaborator, "NRG Oncology" with 16 trials as a collaborator, "Cancer and Leukemia Group B" with 3 trials as a collaborator, "Radiation Therapy Oncology Group" with 3 trials as a collaborator and "Canadian Cancer Trials Group" with 2 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "Cleveland Clinic Cancer Center Strongsville" are "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials), "Breast Cancer" (7 trials), "Recurrent Breast Carcinoma" (5 trials) and "Stage IIIA Lung Non-Small Cell Cancer AJCC v7" (5 trials). Many other conditions were trialed in "Cleveland Clinic Cancer Center Strongsville" in a lesser frequency.

Most popular intervention types in "Cleveland Clinic Cancer Center Strongsville" are "Drug" (85 trials), "Other" (62 trials), "Biological" (38 trials), "Radiation" (32 trials) and "Procedure" (14 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (35 trials), "Quality-of-Life Assessment" (24 trials), "Cisplatin" (16 trials), "Paclitaxel" (14 trials) and "Carboplatin" (12 trials). Other intervention names were less common.

The vast majority of trials in "Cleveland Clinic Cancer Center Strongsville" are 84 trials for "All" genders, 9 trials for "Female" genders and 8 trials for "Male" genders.

Currently, there are NaN active trials in "Cleveland Clinic Cancer Center Strongsville". undefined are not yet recruiting, 26 are recruiting, 49 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in Cleveland Clinic Cancer Center Strongsville, 4 suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Cleveland Clinic Cancer Center Strongsville, 2 "Phase 1" clinical trials were conducted, 47 "Phase 2" clinical trials and 68 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".